Beta-glucosidase mutant and application thereof in hydrolysis of malonyl genistin

By homologous modeling and molecular docking design of β-glucosidase, its amino acid sequence is mutated to enhance the activity of malonyl ligand glycoside, the problem of low utilization efficiency of existing enzymes on soy isoflavones resources is solved, and the problem of existing enzymes is achieved The aglycone generation of soy isoflavones efficiently hydrolyzes soybean isoflavones, which significantly improves resource utilization.

CN118956830AActive Publication Date: 2024-11-15ANHUI UNIV
View PDF 6 Cites 0 Cited by

Patent Information

Application Number
CN202411358848.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-27
Publication Date
2024-11-15
Estimated Expiration
2044-09-27

AI Technical Summary

Technical Problem

The existing β-glucosidase lacks activity on malonyl genistoside in soy isoflavones, resulting in waste of resources and it is difficult to effectively hydrolyze soy isoflavones to form their active form of aglycones.

Method used

Through homologous modeling and molecular docking design, the amino acid sequence of mutant β-glucosidase, especially the glutamine at position Q301, is changed to alanine, which improves the substrate channel capacity of the enzyme and enhances the malonyl dye wood Hydrolytic activity of glycosides and recombinantly expressed and purified in E. coli to prepare mutants.

Benefits of technology

The stability of the mutant is 3.7 times, and the efficiency of hydrolyzing malonyl genistoside is improved. It can hydrolyze 88% of the malonyl genistoside in soybean yellow milk at 35°C, which is higher than the hydrolysis rate of the original enzyme. 1.5 times, significantly improving the efficiency of soy isoflavones converted into aglycone.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118956830A_ABST
    Figure CN118956830A_ABST
Patent Text Reader

Abstract

The invention discloses a beta-glucosidase mutant and an application of the beta-glucosidase mutant in hydrolysis of malonyl genistin. The mutant enzyme with improved malonyl genistin hydrolysis efficiency and stability is obtained by carrying out design and transformation through homologous modeling and molecular docking on the basis of beta-glucosidase from marine uncultured microorganisms. Under the condition of the same mass of zymoprotein, the malonyl genistin hydrolysis ratio of the mutant enzyme is improved by 1.5 times compared with that of the starting enzyme; under the condition of 30-45 DEG C, the half-life period of the mutant enzyme is prolonged by 3.7 times compared with that of a starting enzyme. The mutant has potential application value in producing aglycone by hydrolyzing soy isoflavone.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of biotechnology, and particularly relates to a beta-glucosidase mutant and application thereof in hydrolyzing malonyl genistin. Background Art

[0002] β-Glucosidase (EC 3.2.1.21) belongs to the class of glycoside hydrolases. It was first discovered by Liebig and Wohler in bitter almonds in the 1830s. It can hydrolyze the β-D-glycosidic bond of terminal, non-reducing alkyl-β-glucosides or aromatic-β-glucosides, releasing glucose and the corresponding ligands. β-Glucosidase is active on a variety of substrates and plays a very important role in biofuel production, food processing, pharmaceutical and other industries.

[0003] Soy isoflavones are a mixture of polyphenols, which play an important role in the prevention and treatment of cancer, cardiovascular disease and osteoporosis. There are 12 monomeric forms of isoflavones in nature, which are divided into two forms: glycosides and aglycones. The activity of aglycones is much greater than that of glycosides, and isoflavone aglycones are easily absorbed by the human body. Therefore, converting isoflavone glycosides into aglycones and increasing the content of isoflavone aglycones in soy products has aroused people's interest. Malonyl genistin is one of the soy isoflavones, and the hydroxyl group at the 6' position of genistin is replaced by malonyl. The main form of soy isoflavones in soy flour reported so far is malonyl glycosides, accounting for about 70% of the total amount of soy isoflavones. Soybean yellow pulp water contains soy isoflavones, of which malonyl genistin accounts for about 40%. Soy isoflavones can be hydrolyzed by β-glucosidase to generate aglycones. However, most β-glucosidases have strict specificity for the sugar groups of soy isoflavones and are not active against malonyl glucosides. Therefore, β-glucosidase capable of hydrolyzing malonyl genistin is obtained through design and modification, and is used for hydrolyzing soybean isoflavones in soybean yellow slurry water, thereby avoiding waste of resources. Summary of the invention

[0004] The present invention provides a β-glucosidase mutant and its application in hydrolyzing malonyl genistin. The present invention is based on a mutant of a β-glucosidase derived from an uncultured marine microorganism that has been semi-rationally modified. The mutant is designed by homology modeling and molecular docking, and the mutant is recombinantly expressed and purified in Escherichia coli before characterization and screening, thereby obtaining a β-glucosidase with improved efficiency and stability in hydrolyzing malonyl genistin. When pNPG is used as a substrate, it is measured that the stability of the mutant is increased by 3.7 times. In the soybean isoflavone conversion experiment, 8 mg of the mutant enzyme was added to the reaction system at 35°C for 30 minutes to hydrolyze malonyl genistin in yellow slurry water by about 88%, and the hydrolysis rate of the starting enzyme with the same protein amount under the same reaction conditions was only 35%. These results show that the mutant has potential application value in hydrolyzing soybean isoflavones to produce aglycones.

[0005] The amino acid sequence of the β-glucosidase mutant of the present invention is shown in SEQ ID NO: 1. In the amino acid sequence of the β-glucosidase mutant, the glutamine at position 301 is mutated to alanine.

[0006] The nucleotide sequence of the gene encoding the β-glucosidase mutant is shown in SEQ ID NO:2.

[0007] The strain expressing the beta-glucosidase mutant of the present invention contains the mutant plasmid.

[0008] The strain expressing the β-glucosidase mutant of the present invention is classified and named Escherichia coli BL21 (DE3) / p ET22b (+) -bgl2A: Q301A, and has been sent to the China Center for Type Culture Collection (CCTCC) for preservation, with a preservation number of CCTCC NO: M 20241888, a preservation time of September 2, 2024, and a preservation address: Wuhan University, Wuhan, China.

[0009] The method for constructing a strain expressing a β-glucosidase mutant of the present invention comprises the following steps:

[0010] First, the structure of β-glucosidase SghA (PDB code: 6rjm) of Agrobacterium was used as a template, and Swiss-Model was used to perform homology modeling on the structure of β-glucosidase Bgl2A. Autodock software was used to pre-process the receptor macromolecule (enzyme protein) through steps such as hydrogenation, charge calculation, and adding atom types, and exported to pdbqt format for use. The ligand small molecule malonyl genistin was downloaded from PubChem (https: / / pubchem.ncbi.nlm.nih.gov / ), and the ligand small molecule was pre-processed by Autodock software through steps such as adjusting the charge and selecting the ligand's torsion bond, and exported to pdbqt format for use. Autodock vina was used to perform molecular docking calculations, and Pymol was used to analyze the docking results. Docking has 19 kinds of conformations, according to the direction of the glucose molecule on the malonyl genistin molecule in substrate channel, docking result is divided into two classes, the one is the glucose molecule on the malonyl genistin molecule towards the inside of the substrate channel, the one is the glucose molecule on the malonyl genistin molecule towards the outside of the substrate channel.By the distance analysis of the glycosidic bond distance protein catalytic residue (E170, E352) of binding energy and malonyl genistin, it is preliminarily inferred that glycosidase is when hydrolyzing malonyl genistin, and glucose molecule is towards the inside of the substrate channel.Therefore glucose molecule is analyzed towards six kinds of conformations inside the substrate channel, and the amino acid with malonyl group having hydrogen bond interaction is selected.Wherein comprising Bgl2A:Q301, it is mutated into the amino acid that side chain is smaller i.e. alanine, purpose makes the substrate channel of albumen become larger, can hold larger malonylation glucose group, and then improve the activity of glycosidase to malonyl substrate.

[0011] According to the gene sequence of β-glucosidase Bgl2A, mutation primers were designed and synthesized (Table 1). The recombinant plasmid containing the β-glucosidase Bgl2A gene was used as a template and the above-mentioned synthetic mutation primers were used as primers to perform site-directed mutagenesis based on the overlap extension PCR method ( Figure 1 and Figure 2 ).

[0012] The mutant gene is connected to the pEASY-T3 plasmid and transformed into the competent cells of Escherichia coli Trans1-T1, and the positive clone is picked, and the DNA sequence of the mutant gene is determined. The clone with the correct sequence is selected to extract the plasmid, and the pEASY-T3 recombinant plasmid containing the mutant β-glucosidase gene is obtained. The pEASY-T3 recombinant plasmid and the expression plasmid vector are double-digested with Nde I and Xho I, and then the mutant gene and the expression plasmid vector after the enzyme digestion are ligated with T4 DNA ligase to obtain a ligation product; the ligation product is transformed into a host bacterium, and the positive clone is screened to obtain an engineering strain containing the mutant gene of the present invention.

[0013] The expression plasmid vector described in the above construction method includes pCold, pET15, pET22 or pET28, etc.

[0014] The host bacteria in the above construction method include E. coli BL21 (DE3), E. coli DH5α, E. coli JM109 or E. coli Rosetta and the like.

[0015] The β-glucosidase mutant of the present invention can be obtained by fermentation, expression and purification of the engineering strain ( Figure 3 ).

[0016] The invention discloses an application of the beta-glucosidase mutant in hydrolyzing malonyl genistin.

[0017] The present invention measured and compared the optimum pH, optimum temperature, stability, etc. of the mutant protein and the original starting enzyme protein. The stability of the mutant was improved. Under the conditions of 30-35°C and pH 7.0-7.5, the half-life of the starting enzyme was 1.5h, and the half-life of the mutant Bgl2A:Q301A was 7h. The stability of the mutant was improved by 3.7 times, and the mutation did not cause changes in the optimum temperature and optimum pH ( Figure 4 ).

[0018] In the soy isoflavone hydrolysis experiment, adding 8 mg of the mutant enzyme to the reaction system at 35°C for 30 minutes can hydrolyze the malonyl genistin in the soybean yellow slurry water by about 88%, which is 1.5 times higher than the hydrolysis rate of the starting enzyme with the same protein amount under the same reaction conditions (35%). Figure 5 ). BRIEF DESCRIPTION OF THE DRAWINGS

[0019] Figure 1 , Figure 2 The electrophoretic pattern of the PCR amplification product of the present invention is: Figure 1 The lanes in the middle are DNA marker, PCR amplified fragments Q301A-S, and Q301A-X; Figure 2 The lanes in the middle are the PCR amplification products using DNA marker, Q301A-S and Q301A-X as templates.

[0020] Figure 3 The SDS-PAGE profiles of the purified mutant proteins and the starting enzyme Bgl2A: 1 is the supernatant of Bgl2A, 2 is the precipitate of Bgl2A, 3 is the pure enzyme of Bgl2A, 4 is the supernatant of Q301A, 5 is the precipitate of Q301A, 6 is the pure enzyme of Q301A, and M is a protein marker.

[0021] Figure 4In the figure, a is the optimum temperature measurement result, b is the optimum pH measurement result, and c is the stability measurement result.

[0022] Figure 5 The hydrolysis results of malonyl genistin by the starting enzyme and mutants are shown in Figure 2. DETAILED DESCRIPTION

[0023] The implementation methods in the following embodiments are all conventional methods unless otherwise specified.

[0024] (I) Construction of an expression strain containing the β-glucosidase mutant gene of the present invention

[0025] 1. Selection of β-glucosidase gene mutation sites

[0026] Based on sequence alignment, Bgl2A is most similar to β-glucosidase SghA (PDB code: 6rjm) from Agrobacterium tumefaciens A6, with an amino acid sequence identity of 44%. Using the structure of SghA as a template, Swiss-Model (http: / / swissmodel.expasy.org / ) was used to perform homology modeling on the structure of β-glucosidase Bgl2A.

[0027] Autodock software was used to pre-process the receptor macromolecule (enzyme protein) by adding hydrogen, calculating charges, adding atom types, etc., and then exported to pdbqt format for later use.

[0028] (https: / / pubchem.ncbi.nlm.nih.gov / ), and the ligand small molecule was pre-processed by adjusting the charge and selecting the ligand twistable bond, and then exported to pdbqt format for standby use. Autodockvina was used to perform molecular docking calculations, and Pymol was used to analyze the docking results. There are 19 docking conformations in total. According to the orientation of the glucose molecule on the malonyl genistin molecule in the substrate channel, the docking results are divided into two categories: one is that the glucose molecule on the malonyl genistin molecule faces the inside of the substrate channel, and the other is that the glucose molecule on the malonyl genistin molecule faces the outside of the substrate channel. By analyzing the binding energy and the distance between the glycosidic bond of malonyl genistin and the protein catalytic residue, it is preliminarily inferred that when the glycosidase hydrolyzes malonyl genistin, the glucose molecule faces the inside of the substrate channel. Therefore, the six conformations of the glucose molecule facing the inside of the substrate channel were analyzed, and amino acids with hydrogen bond interactions with the malonyl group were selected. It contains Bgl2A:Q301, which is mutated into alanine, an amino acid with a smaller side chain, in order to enlarge the substrate channel of the protein so as to accommodate malonyl genistin with a larger side chain, thereby increasing the activity of glycosidase towards malonyl substrates.

[0029] 2. Design of mutation primers and PCR amplification of mutant genes

[0030] According to the gene sequence of β-glucosidase Bgl2A: SEQ ID NO: 2 (its amino acid sequence is as SEQ ID NO: 1), and the selected mutation site 301Q, the following 4 site-directed mutagenesis primers were designed (Table 1).

[0031] Table 1 Primer sequences

[0032]

[0033] 3. Construction of expression vector

[0034] The PCR amplification product obtained in step 2 was connected to the pEASY-T3 plasmid, and the following restriction digestion system was established: 10 ng pEASY-T3 vector, 70 ng PCR amplification product, and the connection was carried out at 25°C for 15 min. The ligation product is heat-shocked to transform Escherichia coli Trans1-T1 competent cells, and the obtained transformants are sequenced to verify whether they are mutated; clones with correct sequences are selected to extract plasmids, and pEASY-T3 recombinant plasmids containing the mutant gene of β-glucosidase of the present invention are obtained; the obtained pEASY-T3 recombinant plasmid and pET-22b(+) vector are double-digested with Nde I and Xho I, and then the mutant gene after enzyme digestion is connected to the expression plasmid vector with T4 DNA ligase, and the following enzyme digestion system is established: 25 ng pET-22b(+) vector, 50 ng mutant gene enzyme fragment, 2 μL 10×ligation buffer, 1 μL T4 DNA ligase, water is added to 20 μL, and the connection is carried out at 22° C. for 1 hour to obtain a ligation product; the ligation product is transformed into a host bacterium, and the obtained transformants are sequenced to verify whether they are mutated, and the transformants with correct sequences are selected to obtain the engineering strain Escherichia coli BL21(DE3) / p ET-22b(+)-Bgl2A:Q301A containing the mutant gene of the present invention.

[0035] The strain expressing the β-glucosidase mutant of the present invention is classified and named Escherichia coli BL21 (DE3) / p ET22b (+) -bgl2A: Q301A, and has been sent to the China Center for Type Culture Collection (CCTCC) for preservation, with a preservation number of CCTCC NO: M 20241888, a preservation time of September 2, 2024, and a preservation address: Wuhan University, Wuhan, China.

[0036] (ii) Expression and protein purification of genetically engineered bacteria containing the β-glucosidase mutation of the present invention

[0037] (i) The genetically engineered strain Escherichia coli BL21(DE3) / pET22b(+)-bgl2A:Q301A was inoculated into 400 mL LB liquid medium containing ampicillin and cultured at 37°C and 200 rpm until OD 600The concentration of IPTG was 0.6, and the LB culture medium was used as a blank control; IPTG was added at a final concentration of 0.2mM for induction, and the culture was continued for 16 hours at 16°C and 120rpm; the bacteria were collected by centrifugation at 4°C and 8000g, and 3 times the volume of the bacterial solution was added to Binding buffer. The cells were broken by ultrasound at 350W for 30min under ice bath conditions, and the supernatant was collected by centrifugation at 12000g to obtain the crude enzyme solution. The crude enzyme solution was purified by Ni-NTA column chromatography. The imidazole concentration in the eluent was 60mM, and 3 column volumes were eluted. The obtained protein reached SDS-PAGE purity after detection.

[0038] (III) Detection of specific activity of β-glucosidase mutants

[0039] The reaction system is 500μL. Add pNPG with a final concentration of 5mM to the citrate-Na2HPO4 buffer at pH 6.5. Add the enzyme solution after preheating at 45℃ for 5min. After reacting for 5min, add 500μL 1M Na2CO3 to terminate the reaction. The experimental group performed 3 parallel experiments, and the control group used the buffer solution instead of the enzyme solution. The control group was set to zero and the light absorption value at 405nm was measured. Enzyme activity (U) is defined as the amount of enzyme used to produce 1μmol pNP per minute.

[0040] (IV) Detection of β-glucosidase stability

[0041] Bgl2A and mutants were heat treated at 30-35°C and pH 7.0-7.5. Samples were taken every half an hour or one hour. The initial enzyme activity was taken as 100%. The residual enzyme activity after a certain period of heat treatment was calculated using the following formula: residual enzyme activity = (enzyme activity before heat treatment - lost enzyme activity) / enzyme activity after heat treatment × 100%.

[0042] (V) Application of β-glucosidase mutants in the hydrolysis of soybean isoflavones

[0043] The yellow slurry water treatment process established in the laboratory in the early stage was used to treat the yellow slurry water. First, the volume of the yellow slurry water was concentrated to 1 / 5, and then 3 / 4 of the volume of the concentrated solution was added with anhydrous ethanol. After being fully mixed at room temperature, the solution was centrifuged at 8000rpm for 20 minutes to obtain an isoflavone extraction solution. Since the final concentration of ethanol is high, β-glucosidase is very easy to be inactivated. Therefore, the early process selected to add an equal volume of water to dilute the ethanol concentration to about 20% (v / v), and then add β-glucosidase to hydrolyze isoflavones after adjusting the pH with NaOH; 10ml of yellow slurry water was incubated in a 35℃ water bath for five minutes, 8mg of enzyme was added, and the reaction was reacted for 30min, 1mL of sample was taken, and 1mL of 70% ethanol was immediately added to terminate the reaction. All were controlled without enzyme addition. The terminated reaction solution was taken with a 1mL syringe and passed through a 0.22μm organic and water filter membrane, and the consumption components of the glycoside substrate were detected by HPLC.

Claims

1. A β-glucosidase mutant, whose amino acid sequence is shown in SEQ ID NO:

1.

2. A gene encoding the β-glucosidase mutant according to claim 1, wherein the nucleotide sequence of the gene is shown in SEQ ID NO:

2.

3. The strain expressing the β-glucosidase mutant according to claim 1, characterized in that: The strain is classified and named Escherichia coli BL21(DE3) / p ET22b(+)-bgl2A:Q301A, and has been sent to the China Center for Type Culture Collection (CCTCC) for preservation. The preservation number is CCTCC NO: M 20241888. The preservation date is September 2, 2024. The preservation address is: Wuhan University, Wuhan, China.

4. Use of the β-glucosidase mutant according to claim 1 in the hydrolysis of malonyl genistin.

5. The use according to claim 5, characterized in that: The temperature of the hydrolysis system is 30-35°C, and the pH value is 7.0-7.5.

Citation Information

Patent Citations

  • Glucose-tolerant beta-glucosidase and expression thereof

    CN101955922A

  • Beta-glucosidase variants with improved properties

    CN102844429A

  • Expression vectors, expression engineering bacteria and expression methods of beta-glucosidase mutant protein

    CN106282217A

  • High glucose tolerance beta-glucosidase mutant and gene and application thereof

    CN107142254A

  • Beta-glucosidase mutant with improved stability and application thereof

    CN117683752A